Literature DB >> 1517800

Comparison of myelography combined with postmyelographic spinal CT and MRI in suspected metastatic disease of the spinal canal.

S Helweg-Larsen1, A Wagner, L Kjaer, A Johnsen, J Boesen, T Palner, P S Sørensen.   

Abstract

Comparison between myelography (MY) and magnetic resonance imaging (MRI) was carried out in 36 patients with clinical suspicion of spinal cord or root compression due to metastatic disease in the spinal canal. In 3 patients metastatic lesions were visualized on MY but not on MRI, while there were no cases with a negative MY and a positive MRI. In 44% of the cases MY alone or combined with postmyelographic CT (pm-CT) showed a larger tumor extension than did MRI, while the opposite occurred in 25%. As for detection of bony metastases and tumor masses localized outside the spine there was no difference between MRI and MY + pm-CT. The results indicate that the choice between MRI and MY + pm-CT still can be based on the availability and quality of the procedure at a given institution.

Entities:  

Mesh:

Year:  1992        PMID: 1517800     DOI: 10.1007/bf00172475

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Early diagnosis of spinal metastases by CT and MR studies.

Authors:  L K Colman; B A Porter; J Redmond; D O Olson; G K Stimac; D M Dunning; K E Friedl
Journal:  J Comput Assist Tomogr       Date:  1988 May-Jun       Impact factor: 1.826

2.  Magnetic resonance imaging with gadolinium-DTPA enhancement in the differentiation of benign from neoplastic cord cavitation.

Authors:  C E Clarke; J Hawnaur; E Prvulovich; G M Yuill; C M Bannister
Journal:  Clin Radiol       Date:  1990-03       Impact factor: 2.350

3.  Spinal cord compression due to metastatic disease: diagnosis with MR imaging versus myelography.

Authors:  R F Carmody; P J Yang; G W Seeley; J F Seeger; E C Unger; J E Johnson
Journal:  Radiology       Date:  1989-10       Impact factor: 11.105

4.  Lumbar herniated disk disease and canal stenosis: prospective evaluation by surface coil MR, CT, and myelography.

Authors:  M T Modic; T Masaryk; F Boumphrey; M Goormastic; G Bell
Journal:  AJR Am J Roentgenol       Date:  1986-10       Impact factor: 3.959

5.  Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression.

Authors:  F Bach; B H Larsen; K Rohde; S E Børgesen; F Gjerris; T Bøge-Rasmussen; N Agerlin; B Rasmusson; P Stjernholm; P S Sørensen
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

6.  Gadolinium-enhanced magnetic resonance imaging of spinal tumours.

Authors:  C I Rothwell; T Jaspan; B S Worthington; I M Holland
Journal:  Br J Radiol       Date:  1989-12       Impact factor: 3.039

7.  Cervical myelopathy: a comparison of magnetic resonance and myelography.

Authors:  T J Masaryk; M T Modic; M A Geisinger; J Standefer; R W Hardy; F Boumphrey; P M Duchesneau
Journal:  J Comput Assist Tomogr       Date:  1986 Mar-Apr       Impact factor: 1.826

8.  Comparison of MR and CT myelography in imaging the cervical and thoracic spine.

Authors:  M G Karnaze; M H Gado; K J Sartor; F J Hodges
Journal:  AJR Am J Roentgenol       Date:  1988-02       Impact factor: 3.959

9.  Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scans.

Authors:  E Avrahami; R Tadmor; O Dally; H Hadar
Journal:  J Comput Assist Tomogr       Date:  1989 Jul-Aug       Impact factor: 1.826

10.  Magnetic resonance imaging in the diagnosis of spinal cord diseases.

Authors:  F Aichner; W Poewe; W Rogalsky; K Wallnöfer; J Willeit; F Gerstenbrand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

View more
  1 in total

1.  Primary spinal epidural lymphomas.

Authors:  Goutham Cugati; Manish Singh; Anil Pande; Ravi Ramamurthi; Mahalakshmi Balasubramanyam; Sumer K Sethi; Ajai Kumar Singh
Journal:  J Craniovertebr Junction Spine       Date:  2011-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.